Edition:
India

Sino Biopharmaceutical Ltd (1177.HK)

1177.HK on Hong Kong Stock

9.00HKD
19 Jul 2019
Change (% chg)

HK$0.17 (+1.93%)
Prev Close
HK$8.83
Open
HK$8.92
Day's High
HK$9.15
Day's Low
HK$8.81
Volume
37,268,949
Avg. Vol
52,846,789
52-wk High
HK$11.88
52-wk Low
HK$4.53

Latest Key Developments (Source: Significant Developments)

Sino Biopharmaceutical Says Abiraterone Acetate Tablet Gets Approval For Drug Registration From NMPA
Wednesday, 17 Jul 2019 

July 17 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANTI-TUMOR DRUG ABIRATERONE ACETATE TABLET DEVELOPED BY UNIT GETS APPROVAL FOR DRUG REGISTRATION FROM NMPA.  Full Article

Sino Biopharmaceutical Says Anlotinib Hydrochloride Capsules Obtained Approval For New Indication
Friday, 5 Jul 2019 

July 5 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANLOTINIB HYDROCHLORIDE CAPSULES GOT APPROVAL FOR DRUG REGISTRATION FOR NEW INDICATION FOR TREATMENT OF "SOFT TISSUE SARCOMA".APPROVAL FOR DRUG REGISTRATION GRANTED BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC.  Full Article

Sino Biopharmaceutical Says Unit's Drug Approved For Drug Registration
Thursday, 4 Jul 2019 

July 4 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::UNIT'S ANTITHROMBOTIC DRUG "TICAGRELOR TABLET" APPROVED FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

Sino Biopharmaceutical Says "Tadalafil Tablet" Obtains Approval For Drug Registration
Wednesday, 3 Jul 2019 

July 3 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::SINO BIOPHARMACEUTICAL LTD SAYS "TADALAFIL TABLET" OBTAINS APPROVAL FOR DRUG REGISTRATION.APPROVAL OBTAINED FROM NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PEOPLE'S REPUBLIC OF CHINA.  Full Article

Karolinska Development Announces Final Terms Of Co's Directed Share Issue
Wednesday, 26 Jun 2019 

June 26 (Reuters) - Karolinska Development Ab ::ANNOUNCEMENT OF THE FINAL TERMS AND CONDITIONS OF KAROLINSKA DEVELOPMENT'S DIRECTED SHARE ISSUE TO THE HOLDERS OF THE COMPANY'S CONVERTIBLE LOAN.DIRECTED SHARE ISSUE TO HOLDERS OF CONVERTIBLE LOAN WILL NOT RESULT IN ANY CASH PROCEEDS BEING TRANSFERRED TO COMPANY.ISSUED SHARES WILL BE OFFSET AGAINST PARTS OF OR ENTIRE CONVERTIBLE LOAN INCLUDING ACCRUED INTEREST.SUBSCRIPTION PRICE AMOUNTS TO SEK 3.74 FOR EACH NEW SHARE OF SERIES B.SINO BIOPHARMA TO PARTICIPATE IN ISSUE, WITH PROVISION THAT SINO'S SHARE OF VOTES IN CO SHALL NOT EXCEED 49 % AFTER DIRECTED SHARE ISSUE.MAXIMUM NUMBER OF NEW SHARES OF SERIES B THAT MAY BE ISSUED IN DIRECTED SHARE ISSUE AMOUNTS TO 124.5 MILLION.SINO BIOPHARMA, CERTAIN OTHER OWNERS AGREED TO SUBMIT SUBSCRIPTION COMMITMENTS CORRESPONDING TO THEIR CONVERTIBLE LOAN HOLDING.SINO BIOPHARMA'S COMMITMENT WILL HOWEVER NOT RESULT IN OWNERSHIP IN CO EXCEEDING 49% OF VOTES AND 52.5% OF CAPITAL.CO WILL INITIATE STRATEGIC INITIATIVE TOGETHER WITH SINO BIOPHARMA WITH PURPOSE OF OPENING ASIAN MARKET FOR NORDIC INNOVATIONS.  Full Article

Sino Biopharmaceutical Says Unit Entered Into Joint Venture Contract With Akeso Biopharma
Monday, 17 Jun 2019 

June 17 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::CHIA-TAI TIANQING PHARMACEUTICAL ENTERED INTO JOINT VENTURE CONTRACT WITH AKESO BIOPHARMA, INC. TO ESTABLISH JV CO.REGISTERED CAPITAL OF JV SHALL BE IN RMB689.45 MILLION, OF WHICH RMB344.725 MILLION WILL BE CONTRIBUTED BY CHIA-TAI TIANQING IN CASH.JV FOR PURPOSE TO JOINTLY DEVELOP PROJECT OF RECOMBINANT HUMANIZED ANTI PD-1 MONOCLONAL ANTIBODY AK105 DRUG.  Full Article

Sino Biopharmaceutical Says Antifungal Drug Approved For Drug Registration
Monday, 17 Jun 2019 

June 17 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::ANTIFUNGAL DRUG "CASPOFUNGIN ACETATE FOR INJECTION" APPROVED FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION.  Full Article

Sino Biopharmaceutical Says "Gadoxetate Disodium Injection" Obtains Approval For Drug Registration
Wednesday, 12 Jun 2019 

June 12 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::"GADOXETATE DISODIUM INJECTION" OBTAINS APPROVAL FOR DRUG REGISTRATION BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PRC.  Full Article

Karolinska Development Proposes Measures To Resolve Convertible Loan
Wednesday, 29 May 2019 

May 29 (Reuters) - Karolinska Development AB ::REG-KAROLINSKA DEVELOPMENT'S BOARD OF DIRECTORS PROPOSES MEASURES TO RESOLVE THE COMPANY'S CONVERTIBLE LOAN.DIRECTED ISSUE OF SERIES B SHARES TO HOLDERS OF CONVERTIBLE LOAN ISSUED IN 2015.INITIATES A NEW COLLABORATION WITH SINO BIOPHARMA TO OPEN ASIAN MARKET FOR NORDIC INNOVATIONS..TO FACILITATE CONVERSION OF OUTSTANDING SEK 329 MILLION NOMINAL AMOUNT TOGETHER WITH ACCRUED INTEREST.COMPLETE TERMS OF DIRECTED ISSUE, INCLUDING SUBSCRIPTION PRICE, ARE EXPECTED TO BE ANNOUNCED AT LATEST ON JUNE 26, 2019.SINO BIOPHARMA AND CERTAIN OTHER OWNERS TO SUBMIT SUBSCRIPTION COMMITMENTS CORRESPONDING TO THEIR CONVERTIBLE LOAN.SUBSCRIPTION PRICE PROPOSED TO BE CALCULATED AS VOLUME-WEIGHTED AVERAGE SHARE PRICE (VWAP) 15 TRADING DAYS ENDING TWO DAYS PRIOR TO AGM, WITH DISCOUNT OF 3% APPLIED TO VWAP.PLANS TO SET UP BRANCH OFFICE IN CHINA WITH TASK TO BRIDGE THIS GAP BY OPENING ASIAN MARKET FOR NORDIC INNOVATIONS.  Full Article

Sino Biopharmaceutical Says Unit's Drug Got Approvals Of Drug Supplementary Application
Tuesday, 28 May 2019 

May 28 (Reuters) - Sino Biopharmaceutical Ltd <1177.HK>::PALONOSETRON HYDROCHLORIDE INJECTION MADE BY UNIT GOT 2 APPROVALS OF DRUG SUPPLEMENTARY APPLICATION.APPROVALS BY NATIONAL MEDICAL PRODUCTS ADMINISTRATION OF PEOPLE'S REPUBLIC OF CHINA.  Full Article

Hong Kong shares end lower as Huawei charges fan trade worries

* HSI financial sector sub-index is flat; property sector up 0.5 percent